Apexon, a digital-first technology services company, today announced that it has been named a Leader in the 2024 ISG Provider Lens™ Generative AI (GenAI) Services and Advanced Analytics and AI ...
Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...